NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $282,658 | -18.0% | 4,700 | 0.0% | 0.02% | -20.8% |
| Q4 2022 | $344,745 | -3.4% | 4,700 | 0.0% | 0.02% | -11.1% |
| Q3 2022 | $357,000 | +9.2% | 4,700 | 0.0% | 0.03% | +12.5% |
| Q2 2022 | $327,000 | -30.7% | 4,700 | -17.5% | 0.02% | -17.2% |
| Q1 2022 | $472,000 | -11.4% | 5,700 | -19.7% | 0.03% | -14.7% |
| Q4 2021 | $533,000 | -35.4% | 7,100 | 0.0% | 0.03% | -37.0% |
| Q3 2021 | $825,000 | -20.9% | 7,100 | +51.1% | 0.05% | -19.4% |
| Q2 2021 | $1,043,000 | +68.0% | 4,700 | 0.0% | 0.07% | +45.7% |
| Q1 2021 | $621,000 | -23.6% | 4,700 | 0.0% | 0.05% | -28.1% |
| Q4 2020 | $813,000 | +55.4% | 4,700 | 0.0% | 0.06% | +36.2% |
| Q3 2020 | $523,000 | – | 4,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |